+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years +
All Genders
ID07459062

Study on Using SPCTRone System for Margin Assessment During Breast Conserving Surgery in Breast Cancer Patients

Led by SPCTR · Updated on 2026-03-09

100

Participants Needed

2

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the SPCTRone system to help assess tissue margins during breast conserving surgery for breast cancer patients. This observational study aims to validate the systems ability to classify cancerous and non-cancerous tissue by comparing its spectral biomarker results with the standard histopathological assessments by pathologists. The goal is to optimize an AI model achieving high sensitivity, specificity, accuracy, and negative predictive value in margin classification. The study involves scanning breast tissue specimens during two phases first scanning only sliced tissue samples, and then scanning both whole specimens and sliced tissue. This approach helps collect detailed spectral data to train and improve the AI system. No experimental treatments or drugs are administered as this is an observational study. Participants will undergo breast conserving surgery as planned, with their tissue samples scanned using the SPCTRone system. Researchers will analyze the diagnostic performance of this system over approximately six months. The study monitors how well the system identifies margin status compared to standard pathology results. Participation includes data collection during surgery and follow-up assessments without altering usual care.

CONDITIONS

Brief Title

Spectral Cancer Tissue Recognition - I

Research Team

R

Robin Merjenburgh

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here